These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1899160)

  • 21. The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin.
    Davies SP; Brown EA; Woodrow DF; Phillips ME; Gower PE; Mee AD
    Transplantation; 1991 Oct; 52(4):746-9. PubMed ID: 1926361
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of plasmapheresis in kidney transplantation--a controlled study].
    Vangelista A; Frascà GM; di Felice A; Liviano d'Arcangelo G; Bonomini V
    Z Urol Nephrol; 1986 Jun; 79(6):311-6. PubMed ID: 3529744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence demonstrating poor kidney graft survival when acute rejections are associated with IgG donor-specific lymphocytotoxin.
    Lobo PI; Spencer CE; Stevenson WC; Pruett TL
    Transplantation; 1995 Feb; 59(3):357-60. PubMed ID: 7871565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologic findings and kidney graft outcome in patients with steroid-resistant rejections before and after OKT3 therapy.
    Niebel W; Metz KA; Albrecht KH; Wagner K; Kribben A; Erhard J; Eigler FW
    Transplant Proc; 1990 Aug; 22(4):1764. PubMed ID: 2117802
    [No Abstract]   [Full Text] [Related]  

  • 27. Allocation of cadaver kidneys according to HLA-DR matching alone would result in optimal graft outcome in most recipients.
    Vereerstraeten P; Abramowicz D; Andrien M; Dupont E; De Pauw L; Kinnaert P
    Transplant Proc; 1999; 31(1-2):739-41. PubMed ID: 10083315
    [No Abstract]   [Full Text] [Related]  

  • 28. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
    Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
    J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATG in steroid-resistant acute rejection in living related kidney transplantation: long-term evaluation.
    Bakr MA; Foda MA; Sally S; Sobh MA; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3161-2. PubMed ID: 7998103
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of donor-recipient HLA-DR mismatches and OKT3 prophylaxis on cadaver kidney graft survival.
    Vereerstraeten P; Dupont E; Andrien M; De Pauw L; Abramowicz D; Goldman M; Kinnaert P
    Transplantation; 1995 Aug; 60(3):253-8. PubMed ID: 7645038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
    Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
    [No Abstract]   [Full Text] [Related]  

  • 32. Pilot study on induction treatment with high-dose OKT3: preliminary observations in kidney transplantation.
    Welter HF; Illner WD; Schleibner S; Abendroth D; Hancke E; Groh J; Land W
    Transplant Proc; 1990 Oct; 22(5):2272. PubMed ID: 2120813
    [No Abstract]   [Full Text] [Related]  

  • 33. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft.
    Middleton D; Martin J; Douglas J; McClelland M
    Transplantation; 1994 Oct; 58(7):845-8. PubMed ID: 7940720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation.
    Abouna GM; Kumar MS; Stephan R; Prior JE; Lyons P; Bulova SI; al-Abdullah IH
    Transplant Proc; 1993 Jun; 25(3):2241-2. PubMed ID: 8516886
    [No Abstract]   [Full Text] [Related]  

  • 35. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA; Toledo-Pereyra LH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract]   [Full Text] [Related]  

  • 37. HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy.
    Taylor CJ; Bayne AM; Welsh KI; Morris PJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):210-1. PubMed ID: 8438273
    [No Abstract]   [Full Text] [Related]  

  • 38. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimization of cyclosporine monotherapy--long-term graft function.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.